Contact Us
SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold Immunochromatography)
SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold Immunochromatography)

SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold Immunochromatography)

  • Non-invasive

  • Simple to use

  • Convenient, no devices required

  • Rapid, get a result in 15 minutes

  • Stable, with high accuracy

  • Inexpensive, cost-efficiency

  • Card-like format, detects the nucleocapsid (N) protein of the virus.

  • Gold-labelled SARS-CoV-2 N protein monoclonal antibodies immobilized on the test area, with corresponding antibodies in the quality control area.

  • Swabbed specimens from the nasopharynx or oropharyngeal, result in 15 minutes.

On 26th Jan 2021, report from PEI of an official test that The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) authorized to perform, declared that Lepu SARS-CoV-2 Antigen Rapid Test Kit has fulfilled all the minimum criteria for antigen tests conducted by PEI in consultation with the Robert Koch-Institut (RKI).

Click for full report and related news

Instruction & Result Interpretation

Press Release

Ordering Information

Step 1:

  • Use a swab to collect samples.

Step 2:

  • Peel off adhesive.

Step 3:

  • Insert swab from well B to well A.

Step 4:

  • Add 6 drops of buffer to well A rotate the shaft, two rounds each direction.

Step 5:

  • Fold the left side over, and wait for 15 minutes.

Result Interpretation:


On March 23, Lepu SARS-CoV-2 Antigen Test Kit was granted special approval by the German Federal Institute for Drugs and Medical Devices (BfArM) for self-testing in Germany. This allows the users to apply tests at home with the aid of sample nasal swabs.  


The rapid antigen test is easy to operate compared with PCR testing. It collects the sample from nasopharynx. Users can test by themselves at home where they might feel most comfortable. By following simple instructions, they can get the results ready in 15 minutes.  



On March 17, the European Center for Disease Prevention and Control published an announcement regarding the public’s usage of self-tests to detect SARS-CoV-2. “From a public health perspective, self-tests can offer advantages when used to complement professionally administered RADTs or RT-PCR tests. They can improve the accessibility to testing. They allow individuals to obtain the result very quickly, which could support the early detection of infectious cases and reduce further community transmission.”  

So far, Lepu's anti-covid-19 products have reached over 147 countries worldwide. This time, Lepu home-use antigen test kits facilitated disease control process in Germany and would continue to support that within Europe soon. More details of  Lepu SARS-CoV-2 Antigen Rapid Test Kit, please visit:

Catalogue No.SARS-CoV-2 Antigen Rapid Test KitCE

Provide Total Solution For
Patients With
Cardiovascular Disease
Email us with any questions or inquiries or use our contact data. We would be happy to answer your questions.